Quarterly report pursuant to Section 13 or 15(d)

Schedule of Share Option Activity (Details)

v3.21.2
Schedule of Share Option Activity (Details) - $ / shares
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]    
Number of Options, Beginning Balance 756,383 509,173
Weighted average exercise price, Beginning Balance $ 1.82 $ 1.30
[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3] 8 years 8 months 12 days 7 years 4 months 24 days
Number of Options, Granted 1,229,590 449,926
Weighted average exercise price, Granted $ 4.61 $ 2.01
Number of Options, Additional options to StemoniX option holders 205,856  
Weighted average exercise price, Additional options to StemoniX option holders $ 4.61  
Number of Options, assumed in Merger 55,840  
Weighted average exercise price, Options assumed in Merger $ 45.95  
Number of Options, Exercised (29,916) (12,000)
Weighted average exercise price, Exercised $ 1.24 $ 1.94
Number of Options, Forfeited (34,717) (31,731)
Weighted average exercise price, Forfeited $ 2.00 $ 1.66
Number of Options, Expired (7,000) (38,687)
Weighted average exercise price, Expired $ 1.39 $ 1.24
Number of Options, Ending Balance 2,176,036 876,681
Weighted average exercise price, Ending Balance $ 4.80 $ 1.65
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 9 years 8 years 4 months 24 days
Number of Options, Exercisable 594,199  
Weighted average exercise price, Exercisable $ 5.84  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 7 years 8 months 12 days